Test your basic knowledge |

First Aid Basics

Subjects : health-sciences, first-aid

Instructions:

Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can study here.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.

1. Tumor marker: tartrate - resistant acid phosphatase. Hairy cell leukemia (B- cell neoplasm)
TRAP
nitrosamines (smoked foods) target
abl gene
bcl -2 gene

2. MEN type II and III tyrosine kinase (oncogene)
iron poisoning
ret gene
bone benign tumor
abl gene

3. GIST cytokine receptor (oncogene)
granulomatous disease
c - kit gene
malignant mesenchyme tumor (general)
blood vessels benign tumor

4. Membrane lipid peroxidation - protein modification and DNA breakage.
Neoplasm associated with Down Syndrome
fat benign tumor
benign epithelial tumor
Free radical cell damage

5. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.
Necrosis
DPC gene
aflatoxin target
cigarette smoke target

6. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
Neoplasm associated with Down Syndrome
lung cancer incidence/mortality
p53 gene
granulomatous disease

7. Retinoblastoma - osteosarcoma 13q tumor suppressor (blocks G1 to S phase progression)
Primary tumors that met to brain
Rb gene
Where you see Psammoma bodies
prostate cancer incidence/mortality

8. 32%/13% male
AIDS
cigarette smoke target
prostate cancer incidence/mortality
ret gene

9. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
Napthalene (aniline) dyes target
Red (hemorrhagic) infarcts
DCC gene
cirrosis (alcohol - hepB or C)

10. Liposarcoma
fat malignant tumor
Neoplasm associated with Down Syndrome
prostate cancer incidence/mortality
causes of increased ESR

11. Tumor marker: pancreatic adenocarcinoma
NF2 gene
Leading cause of death in the US
beta - hCG
CA-19-9

12. Mature teratoma in men or malignant teratoma in M/F
Rb gene
fat benign tumor
extrinsic apoptosis
malignant >1 cell type tumor

13. Neurofibromatosis type 1 17q tumor suppressor
NF1 gene
fat benign tumor
DPC gene
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms

14. Esophageal adenocarcinoma

15. PECAM-1
ras gene
Leukocyte extravasation: diapedesis
bone malignant tumor
paraneoplastic effects of renal cell carcinoma - hemangioblastoma

16. Most human cancers - specifically Li - Fraumeni syndrome 17p tumor suppressor (blocks G1 to S phase progression)
paraneoplastic effects of leukemias and lymphomas
arsenic target
Rb gene
p53 gene

17. Papillary (thyroid) - Serous (ovary) - Meningioma - Mesothelioma
CA-125
blood vessels malignant tumor
Where you see Psammoma bodies
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants

18. Colon carcinoma GTPase (oncogene)
Acute inflammatory mediators
prostate cancer incidence/mortality
ras gene
CCl4 target

19. Tumor marker: ovarian - malignant epithelial tumors.
malignant epithelial tumor
beta - hCG
CA-125
Reversible - plasias

20. ADH
blood cell malignant tumors
skeletal muscle benign tumor
Prostatic acid phosphatase
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms

21. ACTH or ACTH- like peptide
paraneoplastic effects of small cell lung carcinoma
p16 gene
S-100
PSA

22. CML tyrosine kinase (oncogene)
abl gene
blood cell malignant tumors
alpha - fetoprotein
malignant epithelial tumor

23. Mature teratoma in women
benign >1 cell type tumor
causes of increased ESR
skeletal muscle benign tumor
paraneoplastic effects of thymoma - small cell lung carcinoma

24. Hyperplasia - metaplasia - dysplasia
Reversible - plasias
c - myc gene
benign epithelial tumor
benign >1 cell type tumor

25. Tumor marker: prostate carcinoma marker.
Autoimmune (Hashimoto's - myasthenia gravis)
Free radical eliminators
Prostatic acid phosphatase
Rb gene

26. Leiomyoma
calcitonin
Where you see Psammoma bodies
DPC gene
smooth muscle benign tumor

27. Wilms' tumor 11p tumor suppressor
WT1 gene
intrinsic apoptosis
S-100
skeletal muscle malignant tumor

28. Adenocarcinoma - papillary carcinoma
DCC gene
Red (hemorrhagic) infarcts
acanthosis nigricans (hyperpig and epidermal thickening)
malignant epithelial tumor

29. TB - fungal infections - syphilis - leprosy - cat scratch fever - sarcoid - Crohn's - Berylliosis.
granulomatous disease
Colon and rectal cancer incidence
p53 gene
paraneoplastic effects of leukemias and lymphomas

30. Cancer
Second - leading cause of death in the US
DPC gene
CA-125
Free radical eliminators

31. Lung (mesothelioma and bronchogenic carcinoma)
calcitonin
Bombesin
vinyl chloride target
asbestos target

32. Squamous cell carcinoma of skin
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
Neoplasm associated with actinic keratosis
ras gene
beta - hCG

33. Lung - liver - intestine or following reperfusion.
Red (hemorrhagic) infarcts
smooth muscle benign tumor
Colon and rectal cancer incidence
DPC gene

34. Tumor marker: thyroid medullary carcinoma
ret gene
Leukocyte extravasation: diapedesis
secondary amyloidosis (reactive systemic)
calcitonin

35. Ligand - receptor interactions. Release of perforin and granzyme B.
extrinsic apoptosis
N- myc gene
Barrett's esophagus (chronic GI reflux)
lung cancer incidence/mortality

36. Sarcoma
smooth muscle benign tumor
NF1 gene
intrinsic apoptosis
malignant mesenchyme tumor (general)

37. Liver (hepatocellular carcinoma)
Where you see Psammoma bodies
smooth muscle malignant tumor
extrinsic apoptosis
aflatoxin target

38. Colon>stomach>pancreas>breast>lung (liver and lung are the most common places for mets)
Primary tumors that met to liver
DPC gene
DCC gene
Napthalene (aniline) dyes target

39. Solid tissues with single blood supply. Heart - kidney and spleen.
erb - B2 gene
skeletal muscle benign tumor
c - myc gene
Pale infarcts

40. Tumor marker: neuroblastoma - lung and gastric cancer
Rb gene
Leukocyte extravasation: migration
beta - hCG
Bombesin

41. Adenoma - papilloma
Prostatic acid phosphatase
benign epithelial tumor
smooth muscle malignant tumor
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)

42. Neuroblastoma transcription factor (oncogene)
Leukocyte extravasation: rolling
N- myc gene
Red (hemorrhagic) infarcts
cirrosis (alcohol - hepB or C)

43. Follicular and undifferentiated lymphomas anti - apoptotic molecule (oncogene)
Bombesin
vinyl chloride target
bcl -2 gene
Leukocyte extravasation: rolling

44. Liver (centrilobular necrosis - fatty change)
Alkylating agents target
CCl4 target
Leading cause of death in the US
dysplastic nevus

45. Hepatocellular carcinoma
Pale infarcts
cirrosis (alcohol - hepB or C)
bone malignant tumor
Alkylating agents target

46. Hyperuricemia (excess NA turnover)
Pale infarcts
paraneoplastic effects of thymoma - small cell lung carcinoma
DCC gene
paraneoplastic effects of leukemias and lymphomas

47. AL
primary amyloidosis
Barrett's esophagus (chronic GI reflux)
Bombesin
calcitonin

48. PTH- related peptide - TGF- beta - TNF - IL-1
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
prostate cancer incidence/mortality
Paget's bone disease
blood vessels malignant tumor

49. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
vinyl chloride target
Primary tumors that met to brain
skeletal muscle malignant tumor
radiation exposure

50. Prostate (blastic) - thyroid - testes - breast (lytic and blastic) - lung (lytic) - kidney (breast and prostate are most common)
extrinsic apoptosis
Primary tumors that met to bone
Autoimmune (Hashimoto's - myasthenia gravis)
blood vessels malignant tumor